Next-Gen Cancer Treatment Technology | #BILLION $ Market #shorts #investing #cancer #cancertreatment

Defence Therapeutics' 2022 Cancer Treatment Technology: Developing Next-Gen Therapies with Proprietary ACCUM™ Tech

Healthcare Stocks to Invest in
"Defence has a technology that I personally call a solution looking for a problem," says Dr. Moutih Rafei, VP Research & Development and Director.

"The beauty of the ACCUM technology, it's extremely versatile."

Currently, Defence is actively working with a group of consultants in order to initiate a Phase One trial for early next year with the goal of completion by early 2024.

Watch full video: https://www.youtube.com/watch?v=KdgUtMbA0jk

Subscribe to receive more investment opportunities and stock market news videos: https://share.hsforms.com/1SfI551UgTlOM_12GMs9vRAd2c0v

Check out more investment videos:
BTV Business Television episodes: https://www.b-tv.com/the-btv-show
CEO Clips: https://www.b-tv.com/ceo-clips
New Listing Alert: https://www.b-tv.com/investor-alerts

Check us out on our socials:
linkedin.com/company/btv-business-television/
twitter.com/BTVCeoClips
instagram.com/btvceoclips/
facebook.com/BTVCEOClips/

#stockmarket #stockmarketnews #stocks #investing #cancertreatment #technology #business #businessnews #stockstobuy #stockstowatch #stocksfortomorrow #nextgen #cancer
#investment #invest #dowjones #investing2022 #longterminvesting #stockstobuy #stocksfortomorrow #stockstowatch #stocks_to_trade_tomorrow #stockspower #investing2022 #investingtips #investingforbeginners #investingforbeginnersguide #marketanalysis #capitalmarkets #capitalmarketmadeeasy